Politis Dimitrios, Konstantakou Panagiota, Bramis Konstantinos, Alexandraki Krystallenia I, Spyroglou Ariadni, Mastorakos George, Anastasiou Ioannis, Papaconstantinou Ioannis, Dimopoulos Meletios A
Second Department of Surgery, Aretaieion University Hospital, Medical School, National and Kapodistrian University of Athens, Greece.
Endocrinology Department, Aretaieion Hospital, Medical School, National and Kapodistrian University of Athens, Greece.
touchREV Endocrinol. 2023 May;19(1):94-97. doi: 10.17925/EE.2023.19.1.94. Epub 2023 Jan 13.
Urothelial cancer is a common neoplasm and metastatic disease correlates with a poor prognosis. Isolated adrenal gland metastases of urothelial carcinoma are quite rare, and management options can decide a patient's prognosis. Herein we report the case of a 76-year-old man with a metachronous solitary adrenal metastasis from a bladder carcinoma, who underwent adrenalectomy as part of his treatment. Furthermore, we discuss the cases of solitary adrenal metastases of urothelial carcinoma available in the literature, to identify key features to direct appropriate treatment of this rare metastatic site of urothelial cancer and improve prognosis and survival. Still, further prospective studies are needed to design effective therapeutic strategies.
尿路上皮癌是一种常见的肿瘤,转移性疾病与预后不良相关。尿路上皮癌孤立性肾上腺转移相当罕见,治疗方案可决定患者的预后。在此,我们报告一例76岁男性患者,患有膀胱癌异时性孤立性肾上腺转移,他接受了肾上腺切除术作为其治疗的一部分。此外,我们讨论了文献中报道的尿路上皮癌孤立性肾上腺转移病例,以确定指导对这种罕见的尿路上皮癌转移部位进行适当治疗的关键特征,从而改善预后和生存率。尽管如此,仍需要进一步的前瞻性研究来设计有效的治疗策略。